Member of the Association of American Physicians
Fernando J. Martinez mainly focuses on Internal medicine, COPD, Idiopathic pulmonary fibrosis, Lung and Surgery. His studies in Internal medicine integrate themes in fields like Gastroenterology, Placebo and Cardiology. His study in COPD is interdisciplinary in nature, drawing from both Exacerbation, Physical therapy, Spirometry and Intensive care medicine.
Fernando J. Martinez works mostly in the field of Intensive care medicine, limiting it down to topics relating to MEDLINE and, in certain cases, Family medicine. His Idiopathic pulmonary fibrosis research includes elements of Fibrosis, Pulmonary fibrosis and Interstitial lung disease. He interconnects Combined pulmonary fibrosis and emphysema, Lung volume reduction surgery and FEV1/FVC ratio in the investigation of issues within Surgery.
Fernando J. Martinez focuses on Internal medicine, COPD, Idiopathic pulmonary fibrosis, Lung and Intensive care medicine. His Internal medicine research includes themes of Gastroenterology, Placebo, Surgery and Cardiology. In his research, Chronic bronchitis is intimately related to Exacerbation, which falls under the overarching field of COPD.
His Idiopathic pulmonary fibrosis research is multidisciplinary, relying on both Fibrosis, Pulmonary fibrosis, FEV1/FVC ratio and Interstitial lung disease. The various areas that he examines in his Lung study include Radiology, Immunology and Pathology. His research in Intensive care medicine intersects with topics in Clinical trial, Disease and MEDLINE.
His main research concerns Internal medicine, COPD, Exacerbation, Pulmonary disease and Intensive care medicine. Many of his studies on Internal medicine apply to Gastroenterology as well. Fernando J. Martinez combines subjects such as Vilanterol, Budesonide, Metered-dose inhaler, Lung and Spirometry with his study of COPD.
Fernando J. Martinez is studying Idiopathic pulmonary fibrosis, which is a component of Lung. His work in Idiopathic pulmonary fibrosis covers topics such as Clinical trial which are related to areas like Randomized controlled trial. His Pulmonary disease research is multidisciplinary, incorporating elements of Disease and MEDLINE.
His scientific interests lie mostly in Internal medicine, COPD, Pulmonary disease, Idiopathic pulmonary fibrosis and Exacerbation. His Internal medicine research integrates issues from Gastroenterology and Cardiology. The COPD study combines topics in areas such as Spirometry, Asthma, Fluticasone propionate and Intensive care medicine.
In Intensive care medicine, Fernando J. Martinez works on issues like Clinical trial, which are connected to Adverse effect and Post-hoc analysis. His study on Pulmonary disease also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Jørgen Vestbo;Suzanne S. Hurd;Alvar G. Agustí;Paul W. Jones.
American Journal of Respiratory and Critical Care Medicine (2007)
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management
Ganesh Raghu;Harold R. Collard;Jim J. Egan;Fernando J. Martinez.
American Journal of Respiratory and Critical Care Medicine (2011)
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
B. R. Celli;W. MacNee;A. Agusti;Antonio R Anzueto.
European Respiratory Journal (2004)
American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch.
American Journal of Respiratory and Critical Care Medicine (2002)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King.
American Journal of Respiratory and Critical Care Medicine (2013)
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.
Alfred Fishman;Fernando Martinez;Keith Naunheim;Steven Piantadosi.
The New England Journal of Medicine (2003)
Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention.
M. S. Niederman;L. A. Mandell;A. Anzueto;J. B. Bass.
American Journal of Respiratory and Critical Care Medicine (2001)
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu;Martine Remy-Jardin;Jeffrey L. Myers;Luca Richeldi.
American Journal of Respiratory and Critical Care Medicine (2018)
Clinical Characteristics of Covid-19 in New York City.
Parag Goyal;Justin J. Choi;Laura C. Pinheiro;Edward J. Schenck.
The New England Journal of Medicine (2020)
Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis
Ganesh Raghu;Kevin J Anstrom;Talmadge E King;Joseph A Lasky.
The New England Journal of Medicine (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: